Search for Clinical Trial Results
Siderosis - 40 Studies Found
Status | Study |
Completed |
Study Name: Efficacy Study in Removing Excess Iron From the Heart Condition:
Date: 2005-03-15 Interventions:
|
Not yet recruiting |
Study Name: Florbetaben as an Amyloid Plaque Marker in Elderly Patients With Focal or Disseminated Superficial Hemosiderosis Condition:
Date: 2016-01-19 Interventions:
|
Terminated |
Study Name: Clinical Importance of Treating Iron Overload in Sickle Cell Disease Condition:
Date: 2009-09-21 Interventions: Drug: deferasirox Treatment starting dose of 20mg/kg/day based on subjects baseline LIC (liver iron conc |
Completed |
Study Name: Extension Study of Iron Chelation Therapy With Deferasirox in β-thalassemia and Rare Chronic Anemia Patients Condition:
Date: 2005-10-14 Interventions: Drug: Deferasirox Deferasirox available as 125 mg, 250 mg or 500 mg tablets |
Recruiting |
Study Name: Confounder-Corrected Quantitative MRI Biomarker of Hepatic Iron Content Condition:
|
Completed |
Study Name: Safety & Efficacy of ICL670 vs. Deferoxamine in Beta-thalassemia Patients With Iron Overload Due to Blood Transfusions Condition: Beta-Thalassemia Date: 2003-06-03 Interventions:
|
Completed |
Study Name: Safety of ICL670 vs. Deferoxamine in Sickle Cell Disease Patients With Iron Overload Due to Blood Transfusions Condition: Anemia, Sickle Cell Date: 2003-08-11 Interventions: Drug: ICL670, deferoxamine Other Name: deferasirox |
Completed |
Study Name: Study Of Efficacy,Safety of Combined Deferasirox and Deferiprone Versus Combined Deferiprone and Desferal In Conditions of Iron Overload Condition:
|
Completed |
Study Name: ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional Iron Overload Treated With Deferasirox Condition: Anemia Date: 2007-04-25 Interventions: Drug: Deferasirox |
Completed |
Study Name: Study of Deferasirox in Iron Overload From Beta-thalassemia Unable to be Treated With Deferoxamine or Chronic Anemias Condition:
|